Protelos Demonstrates Unique Long Term Osteoporotic Fracture Reduction

The results of two landmark studies announced today at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), confirms the evidence based, long-term efficacy of Protelos (strontium ranelate) for the reduction of nonvertebral and vertebral osteoporotic fractures over five years. This is the first time an anti-osteoporotic treatment has demonstrated fracture reduction efficacy after five years of treatment.

Recent Blog Post

Largest Ever Genetic Study of Age of Puberty Includes TwinsUK Contribution

17th July 2024 – by Aaruthy Suthahar In a study published in Nature Genetics, researchers conducted the largest-ever investigation into...

We spoke to TwinsUK researcher Dr Emily Leeming about her new book "Genius Gut: The Life-Changing Science of Eating for Your Second Brain" 

17th July 2024 – by TwinsUK What inspired you to write “Genius Gut”?   I wanted to share that what...

My First Week At TwinsUK

17th July 2024 – Nawal Mohamouod The introductory week of my internship at TwinsUK comprised of a collection of seminars...